{"disease":{"id":"fibrinolysis-hemorrhage","name":"fibrinolysis hemorrhage"},"drugs":{"marketed":[{"drug_id":"aminocaproic-acid","indication_name":"Hyperfibrinolysis Induced Hemorrhage","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Amicar","generic_name":"AMINOCAPROIC ACID","company_name":"Epic Pharma Llc","drug_phase":"marketed","molecular_target":"Plasminogen","drug_class":"Antifibrinolytic Agent [EPC]","quality_score":50,"revenue":null,"mechanism":""}],"pipeline":[],"offLabel":[],"totalMarketed":1,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05806346","title":"Goal-directed vs. Empirical Tranexamic Acid Administrationin Cardiovascular Surgery","phase":"NA","overall_status":"RECRUITING","enrollment_count":764,"lead_sponsor_name":"Konkuk University Medical Center","has_results":false},{"nct_id":"NCT07164300","title":"Comparative Study of Tranexamic Acid Dosing in Cardiac Surgery","phase":"NA","overall_status":"RECRUITING","enrollment_count":150,"lead_sponsor_name":"University of Ioannina","has_results":false},{"nct_id":"NCT03856164","title":"Tranexamic Acid for Prevention of Hemorrhage in Cesarean Delivery","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":110,"lead_sponsor_name":"University of Texas Southwestern Medical Center","has_results":true},{"nct_id":"NCT03897621","title":"The Effect of Tranexamic Acid on Blood Coagulation in Total Hip Arthroplasty Surgery","phase":"NA","overall_status":"COMPLETED","enrollment_count":50,"lead_sponsor_name":"Thomas Jefferson University","has_results":false},{"nct_id":"NCT06667882","title":"Safe Delivery of Thrombolytic Treatment for Pulmonary Embolism Using ClotPro® Viscoelastic Tests","phase":"NA","overall_status":"COMPLETED","enrollment_count":33,"lead_sponsor_name":"Semmelweis University","has_results":false}],"total":5},"guidelines":[],"source":"Drug Landscape verified database"}